Cristina Ramo Tello
Overview
Explore the profile of Cristina Ramo Tello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roos I, Sharmin S, Malpas C, Ozakbas S, Lechner-Scott J, Hodgkinson S, et al.
Mult Scler
. 2024 Aug;
30(9):1163-1175.
PMID: 39087208
Background: Comparisons between cladribine and other potent immunotherapies for multiple sclerosis (MS) are lacking. Objectives: To compare the effectiveness of cladribine against fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting MS....
2.
Sancho-Saldana A, Gil-Sanchez A, Gonzalez-Mingot C, Peralta S, Solana M, Torres P, et al.
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068295
Background: The EMCOVID project conducted a multi-centre cohort study to investigate the impact of COVID-19 on patients with Multiple Sclerosis (pwMS) receiving disease-modifying therapies (DMTs). The study aimed to evaluate...
3.
Uccelli A, Laroni A, Ali R, Battaglia M, Blinkenberg M, Brundin L, et al.
Lancet Neurol
. 2021 Oct;
20(11):917-929.
PMID: 34687636
Background: Mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells, have been proposed as a promising therapeutic option for people with multiple sclerosis on the basis of their immunomodulatory...
4.
Grau Lopez L, Sedano Tous M, Ramo Tello C
Med Clin (Barc)
. 2007 Oct;
129(9):356.
PMID: 17910855
No abstract available.